Lexeo Therapeutics, Inc. (LXEO)

SEC filing

Lexeo Therapeutics, Inc.

LXEO · CIK 1907108

4 · Sep 28, 2026 · Chief Medical Officer Bhalla Narinder Pal was granted 57.46K shares at $0.169/share ($9,713)

Chief Medical Officer Bhalla Narinder Pal was granted 57.46K shares at $0.169/share ($9,713)

xslF345X06/form4-09282026_050906.xml

xslF345X06/form4-09282026_050906.xmlSEC.gov

Graphics and non-inline formats (not embedded below).